Varenicline (champix)-associated manic relapse in bipolar affective disorder. 2010

S MacSuibhne, and T A Giwa, and M D McCauley

UI MeSH Term Description Entries
D011810 Quinoxalines Quinoxaline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068580 Varenicline A benzazepine derivative that functions as an ALPHA4-BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION. 6,7,8,9-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine,Champix,Chantix,Varenicline Tartrate
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D016540 Smoking Cessation Discontinuing the habit of SMOKING. Giving Up Smoking,Quitting Smoking,Stopping Smoking,Cessation, Smoking,Smoking Cessations,Smoking, Giving Up,Smoking, Quitting,Smoking, Stopping,Smokings, Giving Up,Up Smoking, Giving
D018722 Nicotinic Agonists Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission. Cholinergic Agonists, Nicotinic,Cholinergic Agonist, Nicotinic,Nicotinic Agonist,Agonist, Nicotinic,Agonist, Nicotinic Cholinergic,Agonists, Nicotinic,Agonists, Nicotinic Cholinergic,Nicotinic Cholinergic Agonist,Nicotinic Cholinergic Agonists

Related Publications

S MacSuibhne, and T A Giwa, and M D McCauley
January 2011, General hospital psychiatry,
S MacSuibhne, and T A Giwa, and M D McCauley
January 2007, Journal de pharmacie de Belgique,
S MacSuibhne, and T A Giwa, and M D McCauley
August 2007, The American journal of psychiatry,
S MacSuibhne, and T A Giwa, and M D McCauley
May 1992, Journal of affective disorders,
S MacSuibhne, and T A Giwa, and M D McCauley
March 1989, The British journal of psychiatry : the journal of mental science,
S MacSuibhne, and T A Giwa, and M D McCauley
September 1993, The British journal of psychiatry : the journal of mental science,
S MacSuibhne, and T A Giwa, and M D McCauley
February 2007, Revue medicale de Liege,
S MacSuibhne, and T A Giwa, and M D McCauley
January 2010, Journal of psychopharmacology (Oxford, England),
S MacSuibhne, and T A Giwa, and M D McCauley
October 2002, Indian journal of psychiatry,
S MacSuibhne, and T A Giwa, and M D McCauley
December 2022, Psychiatric genetics,
Copied contents to your clipboard!